Arun Krishna, AstraZeneca, on Results from the LAURA Trial: Tagrisso Effectively Combats NSCLC | Docwire News
Arun Krishna, of AstraZeneca, talks about the LAURA Phase III trial, which assessed Tagrisso in NSCLC patients.
Arun Krishna, of AstraZeneca, talks about the LAURA Phase III trial, which assessed Tagrisso in NSCLC patients.
Colchicine, a legacy drug that received a new indication in 2023 for cardiovascular disease, can treat arterial inflammation after a heart attack, a principal investigator…
Albuminuria (urine albumin-to-creatinine ratio [UACR] ≥30 mg/g) and estimated glomerular filtration rate (eGFR) constitute the basis of contemporary kidney disease staging, and are independently associated…
Former MLB player Sean Burroughs reportedly passed away on Thursday after collapsing while coaching his son’s Little League baseball game.
Emissions from gas stoves are associated with an increased risk of pediatric asthma.
RFK Jr. Speaks About Past Health Incidents Including Brain Parasite: RFK Jr. Speaks About , Past Health.. News video on One News Page on Thursday,…
AbstractBackgroundLimited evidence exists regarding efficacy and safety of diuretic regimens in ambulatory, congestion-refractory, chronic heart failure (CHF) patients.ObjectiveTo compare the poten…
This cancer is usually associated with a far riskier habit—but new research pinpoints a curious link to diet, too.
At a median follow-up of 18.1 months, the ORR and CR rates were both 95.7% following liso-cel treatment.
These nursing professional development resources can aid nurses of all stages in renewing certifications, continuing education, and similar efforts to advance their careers.
And she wants her fans to do it too.